Skip to content

Zidovudine

Zidovudine is a pharmaceutical agent commonly prescribed to support HIV Management. It belongs to a class of antiviral medications designed to inhibit the growth of certain viruses. The single listed formulation is Combivir.

Combivir

HIV Infection

300/150mg

Lamivudine with zidovudine as a 300/150mg film-coated tablet, used in the management of HIV infection. Two nucleoside reverse transcriptase inhibitors.

From$1.60/ tabletView

Key points

  • This nucleoside reverse transcriptase inhibitor mimics the building block HIV needs to build its genetic material, halting the virus mid-replication.
  • It is marketed as Combivir, a film-coated tablet combining zidovudine with other antiretrovirals for combination HIV therapy.
  • A history of anaemia, low neutrophil counts, or liver, kidney or bone marrow problems should be reviewed before starting treatment.

What is Zidovudine?

Zidovudine is a medication known as a nucleoside reverse transcriptase inhibitor. It is used to lower the viral load in your body, allowing the immune system to function more effectively in the presence of chronic viral illness. By controlling the replication of the virus, the medication reduces the progression of the disease. This is a core element of HIV Management.

What Zidovudine is used for

This ingredient is primarily used to address HIV Infection. It is frequently used in combination with other active ingredients to form standard treatment regimens. By consistently inhibiting viral enzymes, it assists in maintaining health and reducing complications associated with the virus.

How does Zidovudine work?

The medicine works by mimicking the building blocks the virus uses to create its own genetic material. When the virus attempts to replicate, it incorporates Zidovudine instead of the necessary natural component. This action terminates the chain of viral DNA synthesis, preventing the virus from multiplying and spreading to uninfected cells.

Zidovudine forms

The active ingredient is available in a film-coated tablet formulation. This solid oral dosage form combines Zidovudine with other antiretrovirals to simplify dosing schedules. This combination approach facilitates better adherence to treatment plans compared to managing single-ingredient dosages separately.

Safety overview for Zidovudine

What to check before using this medicine

Review your medical history to identify any pre-existing conditions, specifically those affecting your liver, kidneys, or bone marrow function. Discuss any history of anaemia or neutrophil deficiencies with your provider.

Possible reactions and tolerability

Common responses can include nausea, fatigue, headache, or digestive discomfort. More significant reactions may involve changes in blood cell counts or muscle weakness. Monitor your physical state and energy levels closely during the initial stages of treatment.

Interactions and health factors

Alcohol and other medications that affect liver function may influence how your body processes this medicine. Certain dietary supplements or other antiviral treatments may cause interactions. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.

Further reading